40,000 unit purchase order. New mold in full production with in 2 months..
“For the past several months, Greystone has been preparing for expected growth in our heavy duty pallet sales”, stated Warren Kruger, CEO. Kruger continued, “The costs associated with this effort has had an impact on our reported earnings. As discussed previously, our new generation lighter-weight 100% recycled plastic 48x40 pallet that hits weight requirements with OSHA has been given high marks at many testing facilities in the U.S. and based on that testing, we have just received an initial 40,000-unit purchase order. A new enhanced mold that is expected to be in full production within two months is on order. To meet expected demand, Greystone has ordered an additional injection molding machine which should be operational in about March 2016. This new machine will be manufacturing the new generation 48X40 pallet. Greystone’s plastic tolling services to TriEnda Holdings, LLC are expected to be in full production within the next month which will provide additional revenue. We are continuing to broaden our base of products and customers to enhance our growth in the future.”
Recent GLGI News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 05:36:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 07:10:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 03:47:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 09:17:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 05:58:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2023 08:30:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/28/2023 09:28:37 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 06:22:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM